Search

Background/Objectives: In regions of Africa with a high prevalence of malaria, pregnant women in their first or second trimester should be administered intermittent preventive treatment in pregnancy (IPTp). However, infants may contract malaria despite the IPTp therapy that their mothers have received. The objective of the present investigation was to assess the symptoms and various treatments for neonatal malaria. Methods: Entropy weight and TOPSIS were used to achieve the study goal. The TOPSIS multi-attribute decision-making system was used to assess newborn malaria symptoms and select the optimal treatment, even for mothers receiving IPTp medication during pregnancy. The entropy weight approach calculated TOPSIS attribute weights. The present research used UNICEF data for 14 African nations in 2023. Results: The results indicated that neonates whose mothers received IPTp therapy ultimately contracted malaria, with diarrhea being the primary symptom. It is important to note that health providers administer a combination of zinc and oral rehydration solution (ORS) to infants as the most effective treatment for malaria symptoms, thereby abandoning the first-line treatment for malaria, artemisinin-based combination therapy (ACT). Conclusions: The most effective treatment for neonatal malaria is a combination of zinc and ORS, although less than half of children in Africa have access to ORS. Therefore, the findings of this study may encourage African countries to prioritize co-pack therapy in their procurement and supply, healthcare provider training, and expenditures. This therapy will also help alleviate the symptoms of malaria in neonates. [ABSTRACT FROM AUTHOR]

Featured Application: Potential application of the outcomes of the present study is feasible, for wastewater bioremediation with concurrent cost-efficient biofuel production, along with value-added health product and biofuel development, while also reducing the carbon footprint, certainly after implementation of the necessary regulation sandboxes, to promote environmental and human health protection and also job creation and economy strengthening. In the current study, the cultivation of microalgae on wastewater-based substrates is investigated for an effective natural wastewater treatment that also generates biofuels and value-added products beneficial to human health. Additionally, the health of ecosystems can be evaluated via microalgae. The utilization of microalgae as bioindicators, biofuel producers, and wastewater treatment providers, under the biorefinery concept, is covered in this article. In fact, bioremediation is feasible, and microalgae culture can be used to efficiently process a variety of effluents. Along with wastewater processing and the creation of value-added substances, bioconversion concurrently offers a viable and promising alternative for reducing CO2 greenhouse gas emissions to contribute to climate change mitigation. The microalgal biorefinery being considered as the third generation is unique in that it addresses all the aforementioned problems, in contrast to lignocellulosic biomass from agricultural waste in second-generation biorefineries and edible crops in first-generation biorefineries. In particular, one of the most promising natural resources for the manufacture of biofuel, including biodiesel, bioethanol, biomethane, and biohydrogen, is found to be microalgae. Furthermore, products of high value, like fatty acid methyl esters, astaxanthin, β-carotene, DHA, and EPA can be made. Hence, microalgal biomass offers a substitute for the development of biofertilizers, bioplastics, pharmaceuticals, cosmetics, animal and aquatic feeds, and human nutrition products, thus promoting human and environmental health. [ABSTRACT FROM AUTHOR]